Buy, Sell, Hold: CoreWeave Near $100 Sparks Debate
CoreWeave trades around $100 as a massive backlog tests cash-generation prospects. Q1 results show strong revenue gro...
We evaluate which retirement option—index fund or target date fund—fits your timeline, risk profile, and tax strategy for a smoother retirement.
26,044 articlesCoreWeave trades around $100 as a massive backlog tests cash-generation prospects. Q1 results show strong revenue gro...
A surge of quantum milestones in 2026 is fueling talk that could commercially useful quantum machines may arrive soon...
GameStop’s walking away from a massive pay package marks a dramatic pivot as the company uses its stock to press a bi...
A cruise stock jumps as an activist investor takes a stake, signaling potential governance shifts. This article break...
Solstice and TensorX unveil a financing pact to fund up to $1 billion in European sovereign AI infrastructure, using ...
Energy Transfer is shifting from a pure yield play to a growth story as key midstream projects advance. This long-for...
Strategy faces an $8 billion cash wall over the next two years as STRC trades well below par, sharpening questions ab...
Investors pulled back from spot XRP ETFs this week, registering zero net inflows across seven trading sessions. XRP p...
Bill Maher accepts the Mark Twain Prize at the Kennedy Center, a night that blends comedy with urgent questions about...
As AI buzz grows, blockbuster stocks are priced to perfection. This article explores a contrarian AI stock idea that ...
Curious about Cerebras stock and its three-year outlook? This guide breaks down growth drivers, risks, and three scen...
A patient fund boosted its stake by roughly $7 million in a major packaging company even though the stock trailed the...